Zimmer Biomet director receives new equity awards

Kolli Sreelakshmi reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kolli Sreelakshmi reported acquisition or exercise transactions in this Form 4 filing.

ZIMMER BIOMET HOLDINGS, INC. director Sreelakshmi Kolli received equity-based compensation in the form of derivative awards. On May 22, 2026, Kolli was granted 1,517.274 Restricted Stock Units tied to Zimmer Biomet common stock, increasing her directly held RSUs to 6,875.

On the same date, she was also granted 875.350 Phantom Stock Units under the company’s Deferred Compensation Plan for Non-Employee Directors, bringing her phantom unit balance to 6,662.281. These phantom units are credited on a 1-for-1 basis with Zimmer Biomet common shares and are to be settled in shares of common stock within sixty days after her service as a director ends.

The RSUs are immediately 100% vested but are subject to mandatory deferral until the later of her termination of service as a director or three years after the grant date. Some units and RSUs referenced include amounts accumulated earlier through the plan’s dividend reinvestment and prior-year grants subject to different deferral periods.

Insider Trade Summary

Grant/Award: 2,392.624 shares

Grant/Award 2 txns

Insider Kolli Sreelakshmi

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	875.35	$0.00	$0.00
Grant/Award	Restricted Stock Units	1,517.274	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 6,662.281 contracts (Direct); Restricted Stock Units — 6,875 contracts (Direct)

Footnotes (6)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
4. F4. Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
5. F5. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
6. F6. Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Key Figures

RSUs granted: 1,517.274 units RSUs after grant: 6,875 units Phantom units granted: 875.350 units +5 more

8 metrics

RSUs granted 1,517.274 units Restricted Stock Units granted on May 22, 2026

RSUs after grant 6,875 units Total Restricted Stock Units held directly after transaction

Phantom units granted 875.350 units Phantom Stock Units granted on May 22, 2026

Phantom units after grant 6,662.281 units Total Phantom Stock Units held after transaction

Conversion ratio 1-for-1 Phantom Stock Units convert into common stock 1-for-1

Exercise price field $85.6800 Technical conversion/exercise price shown for phantom units

Settlement window 60 days Phantom units settled within 60 days after service ends

Deferral period 3 years minimum RSUs deferred until at least three years after grant and service end

Key Terms

Restricted Stock Units, Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision, +1 more

5 terms

Restricted Stock Units financial

"The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan"

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors"

dividend reinvestment provision financial

"phantom stock units accrued ... under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan"

A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

mandatory deferral financial

"Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did ZBH director Sreelakshmi Kolli receive on this Form 4?

Director Sreelakshmi Kolli received 1,517.274 Restricted Stock Units and 875.350 Phantom Stock Units tied to Zimmer Biomet common stock as compensation, both classified as grant or award acquisitions rather than open-market purchases or sales.

How many Restricted Stock Units does ZBH director Sreelakshmi Kolli hold after the grant?

After the new grant, Sreelakshmi Kolli directly holds 6,875 Restricted Stock Units. These RSUs are fully vested but are subject to mandatory deferral until the later of her director service ending or three years after the grant date.

What are Zimmer Biomet Phantom Stock Units and how are they settled?

Zimmer Biomet Phantom Stock Units for non-employee directors track the value of common stock on a 1-for-1 basis. They are settled in shares of company common stock within sixty days after the director’s service ends, according to the deferred compensation plan.

Did the ZBH Form 4 show any open-market buying or selling by Sreelakshmi Kolli?

No, the Form 4 reports only grant or award acquisitions of Restricted Stock Units and Phantom Stock Units. There are no open-market purchases or sales; the transactions are compensation-related derivative awards to a non-employee director.

How many Phantom Stock Units does ZBH director Sreelakshmi Kolli hold after this award?

Following the award, Sreelakshmi Kolli holds 6,662.281 Phantom Stock Units under Zimmer Biomet’s Deferred Compensation Plan for Non-Employee Directors. This amount includes units accrued through dividend reinvestment provisions and prior credited balances.

When will Sreelakshmi Kolli’s new Zimmer Biomet RSUs and phantom units be delivered as shares?

The Phantom Stock Units will be settled in common shares within sixty days after Kolli’s director service ends. The granted Restricted Stock Units are fully vested but mandatorily deferred until at least three years after grant and her termination of service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kolli Sreelakshmi

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$85.68(2)	05/22/2026		A		875.35		(3)	(3)	Common Stock	875.35	$0	6,662.281(4)	D
Restricted Stock Units	(2)	05/22/2026		A		1,517.274		(5)	(5)	Common Stock	1,517.274	$0	6,875(6)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

4. Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

5. The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

6. Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Sreelakshmi Kolli (power of attorney previously filed)	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)